- Home
- ALDX vs HYI Comparison
ALDX vs HYI Comparison
Compare ALDX & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- HYI
- Stock Information
- Founded
- ALDX 2004
- HYI 2010
- Country
- ALDX United States
- HYI United States
- Employees
- ALDX N/A
- HYI N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- HYI Investment Managers
- Sector
- ALDX Health Care
- HYI Finance
- Exchange
- ALDX Nasdaq
- HYI Nasdaq
- Market Cap
- ALDX 326.6M
- HYI 270.9M
- IPO Year
- ALDX 2014
- HYI N/A
- Fundamental
- Price
- ALDX $5.81
- HYI $11.95
- Analyst Decision
- ALDX Strong Buy
- HYI
- Analyst Count
- ALDX 2
- HYI 0
- Target Price
- ALDX $9.50
- HYI N/A
- AVG Volume (30 Days)
- ALDX 917.6K
- HYI 50.6K
- Earning Date
- ALDX 08-07-2025
- HYI 01-01-0001
- Dividend Yield
- ALDX N/A
- HYI 9.59%
- EPS Growth
- ALDX N/A
- HYI N/A
- EPS
- ALDX N/A
- HYI N/A
- Revenue
- ALDX N/A
- HYI N/A
- Revenue This Year
- ALDX N/A
- HYI N/A
- Revenue Next Year
- ALDX $29.89
- HYI N/A
- P/E Ratio
- ALDX N/A
- HYI N/A
- Revenue Growth
- ALDX N/A
- HYI N/A
- 52 Week Low
- ALDX $1.14
- HYI $10.99
- 52 Week High
- ALDX $7.20
- HYI $12.24
- Technical
- Relative Strength Index (RSI)
- ALDX 71.16
- HYI 48.60
- Support Level
- ALDX $5.34
- HYI $11.90
- Resistance Level
- ALDX $5.73
- HYI $12.07
- Average True Range (ATR)
- ALDX 0.27
- HYI 0.09
- MACD
- ALDX 0.01
- HYI -0.00
- Stochastic Oscillator
- ALDX 77.36
- HYI 37.41
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About HYI Western Asset High Yield Defined Opportunity Fund Inc.
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. The fund invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.